The Frequency Of Metabolic Syndrome in Patients on Continuous Ambulatory Peritoneal Dialysis and the Association of Developing Metabolic Syndrome With Dialysis Duration
dc.contributor.author | Kayabasi, Hasan | |
dc.contributor.author | Yilmaz, Zulfukar | |
dc.contributor.author | Yildirim, Idris | |
dc.contributor.author | Yildirim, Yasar | |
dc.contributor.author | Kadiroglu, Ali Kemal | |
dc.contributor.author | Yilmaz, M. Emin | |
dc.date.accessioned | 2024-04-24T17:27:33Z | |
dc.date.available | 2024-04-24T17:27:33Z | |
dc.date.issued | 2011 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | OBJECTIVE: To evaluate the characteristics of patients with metabolic syndrome, and the association of developing MS with peritoneal dialysis duration among patients undergoing continuous ambulatory peritoneal dialysis. MATERIAL and METHODS: Fifty-eight nondiabetic CAPD patients were evaluated. Biochemical parameters, blood pressure, length, weight, waist circumference, and body mass indexes were recorded. MS was determined using NCP-ATP III criteria. The patients were divided into 3 groups according to dialysis duration (Group 1: <= 60 months, Group 2: 61-120 months, Group 3: >= 121 months) and the frequency of MS was compared. RESULTS: Twenty-four of 58 patients were male, and MS was present in 22 (37.9%) patients. 14 (82.4%) of 22 patients with MS were female, (p=0.544). There was a statistically significant difference between patients with and without MS regarding age, BMI, waist circumference, PD duration, and triglyceride levels (p<0.05). 55% (n=32) of the patients were in group 1, 34.5% (n=20) in group 2, and 10.5% (n=6) in group 3 (p=0.092). The frequency of MS decreased with prolongation of dialysis duration (50% in group 1, 20% in group 2, and 33,3% in group 3) (p<0.001). CONCLUSION: The frequency of MS among our CAPD patients was 37.9% and it decreased with prolongation of dialysis duration. This result may suggest that alterations in metabolic state, and abandoning glucose-based PD solutions may improve MS criteria. | en_US |
dc.identifier.doi | 10.5262/tndt.2011.1002.09 | |
dc.identifier.endpage | 172 | en_US |
dc.identifier.issn | 1300-7718 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.scopus | 2-s2.0-84857875794 | |
dc.identifier.scopusquality | N/A | |
dc.identifier.startpage | 168 | en_US |
dc.identifier.uri | https://doi.org/10.5262/tndt.2011.1002.09 | |
dc.identifier.uri | https://hdl.handle.net/11468/20048 | |
dc.identifier.volume | 20 | en_US |
dc.identifier.wos | WOS:000217174400009 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.language.iso | tr | en_US |
dc.publisher | Turk Nefroloji Diyaliz Transplantasyon Dergisi | en_US |
dc.relation.ispartof | Turkish Nephrology Dialysis and Transplantation Journal | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Metabolic Syndrome | en_US |
dc.subject | Peritoneal Dialysis | en_US |
dc.subject | Metabolism | en_US |
dc.subject | Cardiovascular Risk | en_US |
dc.title | The Frequency Of Metabolic Syndrome in Patients on Continuous Ambulatory Peritoneal Dialysis and the Association of Developing Metabolic Syndrome With Dialysis Duration | en_US |
dc.title | The Frequency Of Metabolic Syndrome in Patients on Continuous Ambulatory Peritoneal Dialysis and the Association of Developing Metabolic Syndrome With Dialysis Duration | |
dc.type | Article | en_US |